We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Drug dispensing sites should be the first locations equipped with electronic authentication technologies, according to a new PhRMA proposal to secure the supply chain.
Government officials in Europe have significantly ratcheted up their enforcement of pharmaceutical marketing rules, but the recent flurry of legal actions is not necessarily coming from traditional drug regulators, according to a Brussels-based attorney.
The FDA is seeking input from the public on the possible use of color on prescription drug labeling and packaging to determine whether the practice warrants further action by the agency.
HHS Secretary Michael Leavitt announced proposed regulations Jan. 27 that would facilitate the use of electronic prescriptions when the Medicare drug benefit takes effect next January.
The FDA has issued a public call for information on the use of color on pharmaceutical labeling and packaging to determine if the practice is one that warrants further action from the agency.
The recent ratification of the royalty-free EPCglobal UHF Generation 2 standard as an electronic product code (EPC) standard will encourage technology vendors to create EPC/radio-frequency identification (RFID) tools for suppliers and manufacturers, according to a standards organization.
An international toll-free hotline, established by the U.S. Drug Enforcement Administration (DEA), will receive anonymous reports about illegal sales, diversion or abuse of prescription drugs.
The FDA has released a compliance policy guidance to assist pharmaceutical manufacturers with the implementation of radio-frequency identification (RFID) feasibility studies and pilot programs to strengthen the U.S. drug supply chain and to promote the widespread use of RFID technology by 2007.
Pfizer will add radio-frequency identification (RFID) tags to all packages of Viagra sold in the U.S. by the end of 2005 to protect patients against the risk of ingesting counterfeit versions of the drug. Other manufacturers plan to follow Pfizer’s lead.
Seeking to boost supply chain security, a Florida drug distributor is launching a pilot test of DataDot identification technology to authenticate pharmaceutical products.